Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Fecal Blood Test Predicts Lower Gastrointestinal Lesions

By LabMedica International staff writers
Posted on 25 Aug 2011
The immunochemical fecal occult blood test (iFOBT) is effective for predicting lesions in the lower intestine but not in the upper gastrointestinal (GI) tract.

The iFOBT is a useful noninvasive tool to screen for bleeding without symptoms in the lower GI tract and if bleeding is discovered, a colonoscopy is then used to investigate the source of bleeding. More...


Scientists at the National Taiwan University (Taipei, Taiwan) assessed the specificity of iFOBT, looking at a group of 2,796 people including 1,654 men and 1,142 women, who underwent voluntary bidirectional endoscopies and an iFOBT. The mean age of the participants was 49 years who were all asymptomatic of bleeding and of major GI disorders. They had an iFOBT, blood tests, colonoscopy and an upper GI tract endoscopy, as well as being interviewed.

A one-step commercial iFOBT kit with a brush-type sampler (OC-Light, Eiken Chemical Co. Ltd., Tokyo, Japan) was given to all participants. This test has a positive cutoff level of 50 ng/mL. Of the total participants in the study, 397 people (14.2%) had a positive iFOBT result, indicating bleeding. The iFOBT was specific for almost 90% of colorectal cancers, adenomas, and important lower GI lesions. Lower GI lesions were more common (24.1%) compared with those in the upper GI tract (17.9%). Lesions in the lower GI tract were more frequent in iFOBT-positive screens than in negative screens (41.3% versus 21.3%), whereas the frequency of lesions in the upper GI tract was similar in both positive and negative screens.

The authors concluded that the specificity of the iFOBT was almost 90% for predicting colorectal cancer, adenoma, or any important lesion in the lower gastrointestinal tract. Among participants who had a negative colonoscopy, a false-positive result of the immunochemical fecal test was associated with the use of antiplatelet drugs and a low hemoglobin concentration. The overall findings show that the immunochemical fecal test can be used as a specific diagnostic tool. The study was published on August 2, 2011 in the Canadian Medical Association Journal (CMAJ).

Related Links:
National Taiwan University
Eiken Chemical Co. Ltd.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.